[This corrects the article DOI: 10.1016/j.omtn.2023.05.009.].
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11570507 | PMC |
| http://dx.doi.org/10.1016/j.omtn.2024.102378 | DOI Listing |
Publication Analysis
Top Keywords
erratum inhaled
4
inhaled aptamer
4
aptamer therapy
4
therapy hopeful
4
hopeful therapy
4
therapy lung
4
lung disease
4
disease [this
4
[this corrects
4
corrects article
4
Similar Publications
Corrigendum to "Clinical efficacy of inhaled corticosteroids in equine asthma: A meta-analysis and number needed to treat" [Pulm. Pharmacol. Therapeut. (88), March 2025, 102342].
Pulm Pharmacol Ther
December 2024
Respiratory Disease and Lung Function Unit, Department of Medicine and Surgery, University of Parma, Parma, Italy. Electronic address:
Correction: Brandão et al. Genotoxicity and Gene Expression in the Rat Lung Tissue following Instillation and Inhalation of Different Variants of Amorphous Silica Nanomaterials (aSiO NM). 2021, , 1502.
Nanomaterials (Basel)
November 2024
EPIUnit-Instituto de Saúde Pública, Universidade do Porto, Rua das Taipas, 4050-600 Porto, Portugal.
In the original publication [...
View Article and Find Full Text PDFErratum: Inhaled aptamer therapy: A hopeful therapy for lung disease.
Mol Ther Nucleic Acids
December 2024
[This corrects the article DOI: 10.1016/j.omtn.
View Article and Find Full Text PDFCorrigendum: CHF6297: a novel potent and selective p38 MAPK inhibitor with robust anti-inflammatory activity and suitable for inhaled pulmonary administration as dry powder.
Front Pharmacol
October 2024
Corporate Pre-Clinical R&D, Chiesi Farmaceutici S.p.A., Parma, Italy.
[This corrects the article DOI: 10.3389/fphar.2024.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!